These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 24555663)

  • 1. Chromone: a valid scaffold in medicinal chemistry.
    Gaspar A; Matos MJ; Garrido J; Uriarte E; Borges F
    Chem Rev; 2014 May; 114(9):4960-92. PubMed ID: 24555663
    [No Abstract]   [Full Text] [Related]  

  • 2. Chromone as a Privileged Scaffold in Drug Discovery: Recent Advances.
    Reis J; Gaspar A; Milhazes N; Borges F
    J Med Chem; 2017 Oct; 60(19):7941-7957. PubMed ID: 28537720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromones as a privileged scaffold in drug discovery: a review.
    Keri RS; Budagumpi S; Pai RK; Balakrishna RG
    Eur J Med Chem; 2014 May; 78():340-74. PubMed ID: 24691058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total synthesis and antihypertensive activity of (+/-)7,8-dihydroxy-3-methyl-isochromanone-4.
    Liu J; Ren H; Xu J; Bai R; Yan Q; Huang W; Wu X; Fu J; Wang Q; Wu Q; Fu R
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1822-4. PubMed ID: 19233642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of monoamine oxidase by selected C6-substituted chromone derivatives.
    Legoabe LJ; Petzer A; Petzer JP
    Eur J Med Chem; 2012 Mar; 49():343-53. PubMed ID: 22309913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substituted chromones and quinolones as potent melanin-concentrating hormone receptor 1 antagonists.
    Dyck B; Zhao L; Tamiya J; Pontillo J; Hudson S; Ching B; Heise CE; Wen J; Norton C; Madan A; Schwarz D; Wade W; Goodfellow VS
    Bioorg Med Chem Lett; 2006 Aug; 16(16):4237-42. PubMed ID: 16762549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromone Containing Hybrid Analogs: Synthesis and Applications in Medicinal Chemistry.
    Auti PS; Jagetiya S; Paul AT
    Chem Biodivers; 2023 Aug; 20(8):e202300587. PubMed ID: 37332056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges with chromone as a privileged scaffold in drug discovery.
    Silva CFM; Batista VF; Pinto DCGA; Silva AMS
    Expert Opin Drug Discov; 2018 Sep; 13(9):795-798. PubMed ID: 29985064
    [No Abstract]   [Full Text] [Related]  

  • 9. Chrobisiamone A, a new bischromone from Cassia siamea and a biomimetic transformation of 5-acetonyl-7-hydroxy-2-methylchromone into cassiarin A.
    Oshimi S; Tomizawa Y; Hirasawa Y; Honda T; Ekasari W; Widyawaruyanti A; Rudyanto M; Indrayanto G; Zaini NC; Morita H
    Bioorg Med Chem Lett; 2008 Jul; 18(13):3761-3. PubMed ID: 18524594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective 2-(2-phenylethyl)chromones of Imperata cylindrica.
    Yoon JS; Lee MK; Sung SH; Kim YC
    J Nat Prod; 2006 Feb; 69(2):290-1. PubMed ID: 16499335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selected chromone derivatives as inhibitors of monoamine oxidase.
    Legoabe LJ; Petzer A; Petzer JP
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5480-4. PubMed ID: 22850212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and NMR studies of novel chromone-2-carboxamide derivatives.
    Gaspar A; Cagide F; Quezada E; Reis J; Uriarte E; Borges F
    Magn Reson Chem; 2013 Apr; 51(4):251-4. PubMed ID: 23408556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromone 3-phenylcarboxamides as potent and selective MAO-B inhibitors.
    Gaspar A; Reis J; Fonseca A; Milhazes N; Viña D; Uriarte E; Borges F
    Bioorg Med Chem Lett; 2011 Jan; 21(2):707-9. PubMed ID: 21194943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient construction of a 3C-xanthone-linked 3C-chromone scaffold by novel double Michael additions and cyclizations.
    Xie F; Chen H; Hu Y
    Org Lett; 2010 Jul; 12(13):3086-9. PubMed ID: 20533853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of 2,3,6,8-tetrasubstituted chromone scaffolds.
    Dahlén K; Wallén EA; Grøtli M; Luthman K
    J Org Chem; 2006 Sep; 71(18):6863-71. PubMed ID: 16930039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catalytic asymmetric conjugate addition of Grignard reagents to chromones.
    Vila C; Hornillos V; Fañanás-Mastral M; Feringa BL
    Chem Commun (Camb); 2013 Jul; 49(53):5933-5. PubMed ID: 23719970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-Pot Synthesis of Chromone-2-carboxylate Scaffold: An Important Pharmacophore with Diverse Biological Properties.
    Tummanapalli S; Punna SK; Gulipalli KC; Endoori S; Bodige S; Pommidi AK; Medaboina S; Choppadandi S; Boya R; Ganapathi VK; Mamindla DY; Konakalla R; Bodala GK; Bakangari MR; Kottam SD; Jarikote D; Potewar T; Valluri M
    J Org Chem; 2023 Jul; 88(13):8387-8399. PubMed ID: 37358465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromone and chromanone glucosides from Hypericum sikokumontanum and their anti-Helicobacter pylori activities.
    Tanaka N; Kashiwada Y; Nakano T; Shibata H; Higuchi T; Sekiya M; Ikeshiro Y; Takaishi Y
    Phytochemistry; 2009 Jan; 70(1):141-6. PubMed ID: 19121528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromone studies. Part 13. Synthesis and electron-impact mass spectrometric studies of 5-hydroxy-2-isopropyl-7-methoxychromone, a constituent of the medicinal plant Baeckea frutescens, and side-chain analogues.
    Gray CA; Kaye PT; Nchinda AT
    J Nat Prod; 2003 Aug; 66(8):1144-6. PubMed ID: 12932146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromone-2- and -3-carboxylic acids inhibit differently monoamine oxidases A and B.
    Alcaro S; Gaspar A; Ortuso F; Milhazes N; Orallo F; Uriarte E; Yáñez M; Borges F
    Bioorg Med Chem Lett; 2010 May; 20(9):2709-12. PubMed ID: 20382016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.